Microglial activation in Alzheimer disease: Association with APOE genotype

Brain Pathology

Volumn 8, Issue 3, 1998, Pages 439-447

  Egensperger, Rupert ^a   Kösel, Siegfried ^b   Von Eitzen, Ulrich ^b   Graeber, Manuel B ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTE ACTIVATION; MARKER GENE; MICROGLIA; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PHENOTYPE; PROTEIN EXPRESSION;

EID: 0031831690     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1998.tb00166.x     Document Type: Article

References (62)

1. Alzheimer A (1911) Über eigenartige Krankheitsfälle des späteren Alters. Zeitschr ges Neural Psych 4: 356-385
2. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD (1996) Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J Neurosci Res 43: 190-202
3. Banati RB, Gehrmann J, Czech C, Mönning U, Jones LL, König G, Beyreuther K, Kreutzberg GW (1993) Early and rapid de novo-synthesis of Alzheimer bA4-amyloid precursor protein (APR) in activated microglia. Glia 9: 199-210
4. Banati RB, Graeber MB (1994) Surveillance, intervention and cytotoxicity: Is there a protective role of microglia? Dev Neurosci 16: 114-127
5. Barger SW, Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878-881
6. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
7. Breitner JCS (1996) Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol Aging 17: 789-794
8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskeil PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
9. Curran M, Middleton D, Edwardson J, Perry R, McKeith I, Morris C, Neill D (1997) HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease. Neuroreport 8: 1467-1469
10. De Simone R, Giampaolo A, Giometto B, Gallo P, Levi G, Peschle C, Aloisl F (1995) The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 54: 175-187
11. Defigueiredo RJP, Cummings BJ, Mundkur PY, Cotman CW (1995) Color image analysis in neuroanatomical research: Application to senile plaque subtype quantification in Alzheimer's disease. Neurobiol Aging 16: 211-223
12. Dickson DW (1997) The patnogenesis of senile plaques. J Neuropathol Exp Neurol 56: 321 -339
13. Dickson DW, Lee SC, Mattiace LA, Yen SHC, Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 75-83
14. Dickson DW, Sinicropi S, Yen SH, Ko LW, Mattiace LA, Bucala R, Vlassara H (1996) Glycation and microglial reaction in lesions of Aizheimer's disease. Neurobiol Aging 17: 733-743
15. Egensperger R, Kösel S, Mehraein P, Graeber MB (1995) Apolipoprotein E genotype and neuropathological phenotype in sporadic Alzheimer's disease. Soc Neurosci Abstr 21: 1485
16. Egensperger R. Kösel S, Schnabel R, Mehraein P, Graeber MB (1995) Apofipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. Acta Neuropathol 90: 257-265
17. ElKhoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD (1996) Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382: 716-719
18. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD (1996) Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184: 1737-1745
19. Frade JM, Barde YA. Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron 20: 35-41
20. Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, Li X, Kirkpatnck JB (1995) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27: 119-137
21. Graeber MB, Bise K, Mehraein P (1994) CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropathol Appl Neurobiol 20: 406-408
22. Graeber MB, Streit WJ, Kreutzberg GW (1988) The microglial cytoskeleton: vimentin is localized within activated cells in situ. J Neurocytol: 573-580
23. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp NeuroI 54: 276-281
24. Hardy J (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20: 154-159
25. Haruda FD (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45: 2116-2116
26. Konno H, Yamamoto T, Iwasaki Y, Saitoh T, Suzuki H, Terunuma H (1989) la-expressing microglial cells in experimental allergic encephalomyelitis in rats. Acts Neuropathol 77: 472-479
27. Kösel S, Graeber MB (1994) Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol 88: 19-25
28. Kreutzberg GW (1996) Microglia - a sensor for pathological events in the CNS. Trends Neurosci: 19 312-318
29. LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT (1995) Purification of apolipoprotem E attenuates isoform-specific binding to beta-amyloid. J Biol Chem 270: 9039-9042
30. Laskowitz DT, Goel S, Bennett ER, Matthew WD (1997) Apollpoprotein E suppresses glial cell secretion of TNF alpha. J Neuroimmunol 76: 70-74
31. LeBlanc AC, Xue R, Gambetti P (1996) Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia. J Neurochem 66: 2300-2310
32. Li YM, Dickson D, Vlassara H (1996) Enhanced binding of advanced glycation endproducts (AGE) by apo E4 isotype links mechanisms of plaque deposition in Alzheimer's disease. FASEB J 10: A677
33. Mackenzie IRA, Hao CH, Munoz DG (1995) Role of microglia in senile plaque formation. Neurobiol Aging 16: 797-804
34. Mazur-Kolecka B, Frackowiak J, Le Vinelll H, Haske T, Wisniewski HM (1997) Factors produced by activated macrophages reduce accumulation of Alzheimer's betaamyloid protein in vascular smooth muscle cells. Brain Res 760: 255-260
35. McDonald DR, Brunden KR, Landreth GE (1997) Amyloid fibrils activate tyrosine kinase-dependent signaling and Superoxide production in microglia. J Neurosci 17: 2284-2294
36. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285-1291
37. McGeer PL, Itagaki S, McGeer EG (1988) Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol 76: 550-557
38. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7: 84-92
39. Meda L, Cassatella MA, Szendrei Gl, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by beta-amyloid protein and interferongamrna. Nature 374: 647-650
40. Mirra SS, Heyman A, McKeel D, Sumi SM, Grain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
41. Nakai M, Kawamata T, Taniguchi T, Maeda K, Tanaka C (1996) Expression of apolipoprotein E mRNA in rat microglia. Neuroscience Letters 1:41 -44
42. Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyioid beta-protein via a scavenger receptor. Neuron 17: 553-565
43. Perlmutter LS, Scott SA, Barron E, Chui HC (1992) MHC class ll-positive microglia m human brain: Association with Alzheimer lesions. J Neurosci Res 33: 549-558
44. Qiu WQ, Ye Z, Kholodenko D, Seubert P, Selkoe DJ (1997) Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and nonneural cells. J Biol Chem 272: 6641-6646
45. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575-580
46. Roe MT, Dawson DV, Hulette CM, Einstein G, Grain BJ (1996) Microglia are not exclusively associated with plaque-rich regions of the dentate gyrus in Alzheimer's disease. J Neuropathol Exp Neurol 55: 366-371
47. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F (1993) Clinical trial of indornethacin in Alzheimer's disease. Neurology 43: 1609-1611
48. Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53: 429-437
49. Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 47: 387-400
50. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL (1989) A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 48: 674-691
51. Saitoh T, Kang D, Mallory M, Deteresa R, Masliah E (1997) Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia. Gerontology 43: 109-118
52. C, Grain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele epsilon-4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
53. Schmechel DE, Saunders AM, Strittmatter WJ, Grain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid b-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90: 9649-9653
54. Shigematsu K, McGeer PL, Walker DG, Ishii T, McGeer EG (1992) Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damage. J Neurosci Res 31: 443-453
55. Stone DJ, Rozovsky I, Morgan TE, Andersen CP, Hajian H, Finch CE (1997) Astrocytes and microglia respond to estrogen with increased APOE mRNA in vivo and in vitro. Exp Neurol 143: 313-318
56. Streit WJ, Graeber MB, Kreutzberg GW (I989a) Expression of la antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury. Exp Neurol 105: 115-126
57. Streit WJ, Graeber MB, Kreutzberg GW (1989b) Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol 21: 117-123
58. Strittmatter WJ, Saunders AM, Schmechel D, PericakVance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: High-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Nail Acad Sci USA 90: 1977-1981
59. Uchihara T, Duyckaerts C, He Y, Kobayashi K, Seilhean D, Amouyel P, Hauw JJ (1995) APOE immunoreactivity and microglial cells in Alzheimers disease brain. Neuroscience Letters 1: 5-8
60. Van SD, Chen X, Fu J, Chen M, Zhu HJ, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691
61. Van SD, Zhu HJ, Fu J, Van SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stem D, Schmidt AM (1997) Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 10: 5296-5301
62. Zubenko GS, Stiffier S, Stabler S, Kopp U, Hughes HB, Cohen BM, Moossy J (1994) Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet 54: 199-205